An observational study in Overweight and Obesity and Metabolic Syndrome, sponsored by University of Roma La Sapienza. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-12-06.
Sponsored by University of Roma La Sapienza · Observational
Among 25 studies in Obesity by University of Roma La Sapienza — 3 open to participants now, 4 under way, none of them phase 3. Obesity · University of Roma La Sapienza.
Among the 25 studies in Obesity by University of Roma La Sapienza, this one is one of 2 that started in 2016, is one of 8 observational ones, and was the 10th registered.
11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.
Browse Obesity studies →3 of the 25 studies in Obesity by University of Roma La Sapienza are open now, in 6 countries. Recruiting first, the newest first:
University of Roma La Sapienza · Sites in Italy
University of Roma La Sapienza · Sites in United States, Australia, Brazil and 3 more countries
University of Roma La Sapienza · Sites in Italy
By country, each count listing its studies:
Of the 1,336 Obesity studies recruiting now, 377 (28%) set no upper age limit and 856 (64%) stop at 75 or younger; 168 take children under 18; 491 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 2 started in 2016.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 69 is below the median of 114 across 2,154 observational studies indexed under Obesity.
Median enrollment 44 across the 17 interventional studies, 86 across the 8 observational. Of the 16 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Roma La Sapienza is the lead sponsor of 398 studies on the registry; 56 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 25 studies in Obesity by University of Roma La Sapienza, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to identify new morphological and quantitative magnetic imaging parameters of pituitary gland and sellar region in overweight and obese patient at baseline and after 3 years, dividing patients in 3 groups (weight loss through diet and lifestyle changes, weight loss through bariatric surgery, no weight loss)
This longitudinal prospective study in overweight and obese patients aims to identify and characterize new morphological and quantitative MRI parameters of pituitary gland and sellar region assessed by texture analysis with a specific software (ImageJ©). These parameters will be correlated them to hypothalamic-pituitary-peripheral axis function, metabolism and body composition.
Data will be detected at baseline and at 3 years follow-up to quantitatively identify the different pituitary MRI patterns in 3 groups:
11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.
This study's enrollment of 69 is below the median of 114 across 2,154 observational studies indexed under Obesity.
Browse Obesity studies →University of Roma La Sapienza is the lead sponsor of 398 studies on the registry; 56 are open to participants now.
Compared within Obesity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Overweight. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Overweight and obese patients come to our attention for weight loss interventions
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Obese patients with indication to bariatric surgery
Procedure: Bariatric surgery
Overweight or obese patients without indication to bariatric surgery, able to obtain weight loss trough diet and lifestyle changes
Behavioral: Diet and lifestyle changes
Overweight or obese patients without indication to bariatric surgery, not able to obtain weight loss trough diet and lifestyle changes
Behavioral: Diet and lifestyle changes
Also known as: sleeve gastrectomy, gastric bypass, bilio-intestinal bypass
Also known as: hypocaloric diet, physical exercise
Pituitary volume
Change in pituitary volume (mm3) from baseline to 3 years
Time frame: 0, +3 years
Evaluation of pituitary mean and standard deviation intensity
Changes in new quantitative magnetic imaging parameters of pituitary gland from baseline to 3 years
Time frame: 0, +3 years
Correlation of magnetic resonance parameters with anthropometric measurements
Correlation analysis of pituitary mean and standard deviation intensity with anthropometric measurements
Time frame: 0, +3 years
Correlation of magnetic resonance parameters with pituitary axis function
Correlation analysis of pituitary mean and standard deviation intensity with pituitary axis function
Time frame: 0, +3 years
Correlation of magnetic resonance parameters with glyco-metabolic status
Correlation analysis of pituitary mean and standard deviation intensity with glyco-metabolic status
Time frame: 0, +3 years
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Nov 2016 to primary completion in Jun 2020, 43 months.
Of 791 non-industry observational studies under Obesity, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 106. This study's 43 months is close to that.
Counting every sponsor, half of 836 studies reached it within 39 months; a quarter within 17 and three quarters within 96.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Roma La Sapienza →